Combination therapy, utilizing Aromatase Inhibitors (AIs) alongside targeted agents, has emerged as one of the promising approaches in the treatment of hormone-sensitive breast cancer in postmenopausal women. This is because endocrine or hormonal therapy was found effective in hormone-sensitive breast cancer for a considerable period of time.
Hello
There is reasonable evidence that this article is machine-generated.
We would appreciate it if you could avoid publishing AI-generated content (full or partial texts, art, etc.).
Thank you.
Guide: AI-Generated Content = Not Original Content
If you believe this comment is in error, please contact us in #appeals in Discord.